RRGENER Therapeutics Secures Over RMB 100 Million in Pre-A Financing to Advance Preclinical Development and Delivery Platform

By | Pharma Insights

Recently, RRGENER officially announced the completion of its Pre-A strategic financing round, exceeding RMB 100 million. To date, RRGENER has secured investments and support from multiple institutions, including Loyal Valley Capital, Renjin Investment, LC Ventures, E Fund Capital, Zhenji Capital, and Ruihua Capital. The proceeds from this round will be primarily allocated to the preclinical development of its products and the construction of its delivery technology platform.

(Original text abridged)

▽Follow 【WuXi AppTecVirtue】WeChat Official Account